Anti VEFG Agents In Retinal Diseases
Anti-vascular endothelial growth factor (Anti VEGF) agents are emerging as the most vital tool in the prevention of blindness due to ocular neovascularization in modern medicine. VEGFs are glycoproteins specific to endothelial cells, acting as key regulators of angiogenesis, vasculogenesis, and incr...
Saved in:
| Main Author: | Khushboo Chawla |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2022-01-01
|
| Series: | Delhi Journal of Ophthalmology |
| Subjects: | |
| Online Access: | https://journals.lww.com/10.7869/djo.755 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Systemic Effects of Intravitreal Anti-VEGF Therapy: A Review of Safety across Organ Systems
by: Mousumi Banerjee, et al.
Published: (2025-06-01) -
Modern concept of a new group of retinal vasculitis
by: I. A. Loskutov, et al.
Published: (2022-01-01) -
Effect of Intravitreal Anti-Endothelial Growth Factor Agents on Renal Function in Patients With Diabetes Mellitus
by: Marta Rivero, et al.
Published: (2024-05-01) -
Comparison of intravitreal anti-VEGF agents and oral carbonic anhydrase inhibitors in the treatment of cystoid macular edema secondary to retinitis pigmentosa
by: Jia Liang, et al.
Published: (2024-12-01) -
Vascular Endothelial Growth Factors: Pharmacological aspects and applications in ophthalmic practices
by: Ashok K Dubey, et al.
Published: (2013-10-01)